Department of Pediatric Hematology, Medical Faculty, Cukurova University, Adana, Turkey.
Haemophilia. 2012 May;18(3):426-30. doi: 10.1111/j.1365-2516.2011.02706.x. Epub 2011 Dec 19.
Circumcision is the oldest and most frequent surgical procedure in the world and especially in Turkey as is seen in the other Islamic countries because of religious and traditional pressures. In this study, we aim to report the experience of circumcision at Çukurova University in a total of 76 patients with haemophilia between 1990 and 2011. We retrospectively reviewed medical records of 69 haemophilia patients without inhibitors and seven haemophilia patients with inhibitors who had been circumcised. Before the year 2000, factor concentrates were given before and after circumcision for 6-7 days. After 2000, we used fibrin glue together with factor concentrates for only 3 days. By-passing agents were used for circumcision in haemophilia patients with inhibitors. Twelve of 69 patients without inhibitors were referred to our centre with bleeding after the circumcision before diagnosis of haemophilia. Nine of these twelve patients had severe life threatening bleeding and three of them had moderate bleeding. Sixty-four patients with haemophilia were circumcised in our centre under general anaesthesia except for three patients who were given local anaesthesia. Thirteen of 57 haemophilia patients (22.8%) without inhibitors had seven mild and six moderate bleeding complications. A few patients had significant bleeding, despite adequate factor replacement. Five of seven haemophilia patients with inhibitors had two moderate and three mild bleeding complications. Our experience showed that circumcision for patients with haemophilia should be carefully performed by surgeons together with paediatric haematologist, under appropriate conditions in haemophilia centres which has comprehensive coagulation lab.
割礼是世界上最古老、最常见的手术,尤其是在土耳其以及其他伊斯兰国家,这是由于宗教和传统的压力。在这项研究中,我们旨在报告在Çukurova 大学对 76 名血友病患者进行割礼的经验,这些患者的时间范围为 1990 年至 2011 年。我们回顾性地分析了 69 名无抑制剂血友病患者和 7 名有抑制剂血友病患者的医疗记录。在 2000 年之前,在割礼前后给予因子浓缩物 6-7 天。2000 年以后,我们仅使用纤维蛋白胶和因子浓缩物 3 天。有抑制剂的血友病患者在割礼时使用旁路剂。在诊断为血友病之前,有 12 名无抑制剂的 69 名患者因割礼后出血而被转至我们中心。这 12 名患者中有 9 名患有严重危及生命的出血,其中 3 名患有中度出血。除了 3 名接受局部麻醉的患者外,我们中心对 64 名血友病患者在全身麻醉下进行了割礼。在 57 名无抑制剂的血友病患者中,有 13 名(22.8%)有 7 次轻度和 6 次中度出血并发症。尽管进行了充分的因子替代,但少数患者仍有明显出血。有 7 名有抑制剂的血友病患者中有 5 名有 2 次中度和 3 次轻度出血并发症。我们的经验表明,割礼应由外科医生与儿科血液病学家一起在具有综合凝血实验室的血友病中心在适当条件下谨慎进行。